Pinnacle Wealth Management Advisory Group 13F: Cuts LRCX Stake by $967K

Pinnacle Wealth Management Advisory Group trimmed its investment in Lam Research Corporation LRCX, reducing its holdings by 2,944 shares during the period. According to a Form 13F filing with the SEC on October 23, 2026, the firm held 23,294 shares worth about $7.65 million at the close of the quarter. That change equaled an 11.2% drop from its prior total of 26,238 shares.

LRCX Lam Research Corporation

$230.10 ▲ +24.71% year to date

1M 3M YTD

Daily close · Oct 23, 2026

What Changed in Pinnacle Wealth Management's Lam Research Position

The fund lowered its exposure to the semiconductor equipment maker by shedding a fraction of its holdings. The remaining stake of 23,294 shares represented a notable reduction from the 26,238 shares held previously.

Other Institutional Activity in Lam Research

Other institutional investors also adjusted their positions in the semiconductor equipment maker. Livforsakringsbolaget Skandia, Omsesidigt grew its holdings by 7,400 shares, ending with 109,498 shares worth about $35.97 million. Annex Advisory Services grew its holdings by 112,156 shares, ending with 113,371 shares worth about $37.24 million. BSN CAPITAL PARTNERS sold all 133,172 shares it held, ending with 0 shares worth about $0. Wilmington Savings Fund Society, FSB grew its holdings by 10,242 shares, ending with 16,516 shares worth about $5.43 million. Royal Fund Management sold all 49,479 shares it held, ending with 0 shares worth about $0.

Lam Research Corporation Stock Down 11.8%

Shares of Lam Research closed at $230.10 on October 23, 2026, and recently traded around $230.14 as of October 24, 2026. The stock sits below its 50-day moving average of $304.53 and far below its 52-week high of $438.50, though it remains above its 52-week low of $135.50.

Recent Earnings

Lam Research posted trailing twelve month revenue of $26.13 billion alongside earnings of $5.92 per share. The company generated a net profit margin of 32.3% and a return on equity of 70.1%. Its next quarterly earnings report is scheduled for release on January 27, 2027.

Dividend

Lam Research pays an annual dividend rate of $1.32 per share, translating to a dividend yield of 0.57%. The payout ratio stands at 18.1% of earnings.

Insider Buying and Selling at Lam Research Corporation

Several company insiders completed transactions prior to the filing. Officer Ava Harter sold 5,000 shares on August 31, 2026, at an average price of $302.46 for a total value of $1,512,300. Officer Seshasayee Varadarajan sold 59,750 shares on September 2, 2026, at $291.32 per share totaling $17,406,370. Chief Executive Officer Timothy M. Archer sold 30,000 shares on September 9, 2026, at $319.26 for a total of $9,577,800. Director Bethany J. Mayer sold 9,557 shares on September 9, 2026, at $314.74 for $3,007,970.

Analysts Set New Price Targets

Wall Street research firms updated their outlooks on the stock ahead of the filing. UBS maintained a buy rating while lowering its price target to $400.00 from $425.00 on October 22, 2026. Citigroup maintained a buy rating while lowering its price target to $435.00 from $450.00 on October 22, 2026. Morgan Stanley maintained an overweight rating while lowering its price target to $339.00 from $385.00 on October 22, 2026. Mizuho maintained an outperform rating while lowering its price target to $360.00 from $365.00 on October 22, 2026. Needham maintained a buy rating while lowering its price target to $290.00 from $390.00 on October 22, 2026. Wall Street analysts hold a strong buy consensus on the stock with a mean price target of $364.03.

About Lam Research

Lam Research Corporation designs, manufactures, and services semiconductor processing equipment used to build integrated circuits globally. Its tools support chipmakers as they fabricate advanced microchips across facilities in the United States, Asia, and Europe.

Bottom Line

Investors will look toward the company's upcoming earnings report on January 27, 2027, for further updates on order momentum. Future SEC filings will show whether other wealth managers continue trimming exposure or reverse course.